Lv1
48 积分 2023-06-01 加入
MTARC1 Inactivation Remodels Lipid Droplets to Protect Against Metabolic Fatty Liver Disease
5天前
已完结
RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059
20天前
已完结
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
27天前
已完结
Impact of a CD36 inhibitor on Porphyromonas gingivalis mediated atherosclerosis
30天前
已完结
Fatty Acid Transport and Signaling: Mechanisms and Physiological Implications
30天前
已完结
CD36-mediated endocytosis of proteolysis-targeting chimeras
1个月前
已完结
GPR110 as a regulator of MASH
1个月前
已完结
Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signalling
1个月前
已完结
A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse models of chronic liver disease
1个月前
已关闭
皖公网安备34019202002308
